Understanding Health Care Costs in a Wisconsin Acute Leukemia Population
Purpose: We investigated factors driving health care costs of patients with a diagnosis of acute myeloid and acute lymphoblastic leukemia. Methods: Standard costs identified in insurance claims data obtained from the Wisconsin Health Information Organization were used in a sample of 837 acute le...
Main Authors: | Patricia Steinert, Ron A. Cisler |
---|---|
Format: | Article |
Language: | English |
Published: |
Advocate Aurora Health
2016-08-01
|
Series: | Journal of Patient-Centered Research and Reviews |
Subjects: | |
Online Access: | http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1261&context=jpcrr |
Similar Items
-
Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia
by: Sergio Rodríguez-Rodríguez, et al.
Published: (2021-10-01) -
Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol
by: Hadi Hayati, et al.
Published: (2016-09-01) -
Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting
by: Alexander Russell-Smith, et al.
Published: (2023-12-01) -
Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
by: Tushar Mungle, et al.
Published: (2023-02-01) -
Socioeconomic cost of AML in Sweden—A population‐based study using multiple nation‐wide registers
by: Emma Hernlund, et al.
Published: (2021-08-01)